Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 688

1.
2.

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.

Strohmaier K, Snyder E, DuBiner H, Adamsons I.

Ophthalmology. 1999 Dec;106(12 Suppl):1-9.

PMID:
10598691
3.
4.

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide.

Boyle JE, Ghosh K, Gieser DK, Adamsons IA.

Ophthalmology. 1999 Dec;106(12 Suppl):10-6.

PMID:
10598692
6.
7.

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.

PMID:
12623832
8.
9.
10.

A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.

Simpson AJ, Gray TB, Ballantyne C.

Aust N Z J Ophthalmol. 1996 Feb;24(1):39-42.

PMID:
8743003
12.

The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.

Manni G, Denis P, Chew P, Sharpe ED, Orengo-Nania S, Coote MA, Laganovska G, Volksone L, Zeyen T, Filatori I, James J, Aung T.

J Glaucoma. 2009 Apr-May;18(4):293-300. doi: 10.1097/IJG.0b013e31818fb434.

PMID:
19365194
13.

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups..

Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.

14.

Efficacy and safety of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure.

Shin DH, Feldman RM, Sheu WP; Fixed Combination Latanoprost/Timolol Study Group..

Ophthalmology. 2004 Feb;111(2):276-82.

PMID:
15019375
17.

A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.

Strahlman E, Tipping R, Vogel R.

Am J Ophthalmol. 1996 Aug;122(2):183-94. Erratum in: Am J Ophthalmol 1996 Dec;122(6):928.

PMID:
8694086
19.

Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.

Adamsons IA, Polis A, Ostrov CS, Boyle JE.

J Glaucoma. 1998 Dec;7(6):395-401.

PMID:
9871861
20.

Supplemental Content

Support Center